TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T23787	Renal carcinoma antigen NY-REN-56	B18JCP	1-(Pyridin-4-yl)-3-(quinolin-2-yl)prop-2-en-1-one	Investigative	25142799	C17H12N2O	260.29	C1=CC=C2C(=C1)C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3	IC50 > 1000000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	B7OT2I	4-Bromo-5-(morpholin-4-yl)-2-phenylpyridazin-3(2H)-one	Investigative	733090	C14H14BrN3O2	336.18	C1COCCN1C2=C(C(=O)N(N=C2)C3=CC=CC=C3)Br	IC50 > 1000000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	B7Y1SG	4-Bromo-5-(oxolan-2-ylmethylamino)-2-phenylpyridazin-3-one	Investigative	76332026	C15H16BrN3O2	350.21	C1CC(OC1)CNC2=C(C(=O)N(N=C2)C3=CC=CC=C3)Br	IC50 > 1000000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	BAEV49	2-[(5-Bromo-6-oxo-1-phenylpyridazin-4-yl)amino]acetamide	Investigative	76328355	C12H11BrN4O2	323.15	C1=CC=C(C=C1)N2C(=O)C(=C(C=N2)NCC(=O)N)Br	IC50 > 1000000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	BEP27Z	4-Bromo-5-(2-oxa-6-azaspiro[3.3]heptan-6-yl)-2-phenylpyridazin-3-one	Investigative	76317435	C15H14BrN3O2	348.19	C1C2(CN1C3=C(C(=O)N(N=C3)C4=CC=CC=C4)Br)COC2	IC50 > 1000000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	BH5ZX1	2-(5-Bromo-6-oxo-1-phenylpyridazin-4-yl)-3,4-dihydro-1H-isoquinoline-5-carbonitrile	Investigative	76310214	C20H15BrN4O	407.3	C1CN(CC2=C1C(=CC=C2)C#N)C3=C(C(=O)N(N=C3)C4=CC=CC=C4)Br	IC50 > 500000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	BLO24N	5-(4-Acetyl-5-methyltriazol-1-yl)-4-bromo-2-[[4-[2-(dimethylamino)ethylamino]phenyl]methyl]pyridazin-3-one	Investigative	76328354	C20H24BrN7O2	474.4	CC1=C(N=NN1C2=C(C(=O)N(N=C2)CC3=CC=C(C=C3)NCCN(C)C)Br)C(=O)C	IC50 > 500000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	BMK15C	3H-Benzo[e]indol-2-yl(pyridin-4-yl)methanone	Investigative	53374134	C18H12N2O	272.3	C1=CC=C2C(=C1)C=CC3=C2C=C(N3)C(=O)C4=CC=NC=C4	IC50 > 1000000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	BO3N2L	5-(4-Acetyl-5-methyltriazol-1-yl)-2-phenyl-4-propan-2-ylpyridazin-3-one	Investigative	76321168	C18H19N5O2	337.4	CC1=C(N=NN1C2=C(C(=O)N(N=C2)C3=CC=CC=C3)C(C)C)C(=O)C	IC50 > 500000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	BO4UH1	5-(4-Acetyl-5-methyltriazol-1-yl)-4-ethoxy-2-phenylpyridazin-3-one	Investigative	76328357	C17H17N5O3	339.3	CCOC1=C(C=NN(C1=O)C2=CC=CC=C2)N3C(=C(N=N3)C(=O)C)C	IC50 > 1000000 nM	Non binder
T23787	Renal carcinoma antigen NY-REN-56	BQ5DZ0	5-(4-Acetyl-5-methyltriazol-1-yl)-2-benzylpyridazin-3-one	Investigative	76335630	C16H15N5O2	309.32	CC1=C(N=NN1C2=CC(=O)N(N=C2)CC3=CC=CC=C3)C(=O)C	IC50 > 10000000 nM	Non binder